Doctors hail first breakthrough in asthma and COPD treatment in 50 years
Doctors hail first breakthrough in asthma and COPD treatment in 50 years
Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world
Summary
A new treatment for severe asthma and COPD, using the monoclonal antibody benralizumab, could revolutionize care after a 50-year stagnation in treatment methods.
A trial showed that a single high-dose injection during flare-ups was 30% more effective than standard steroid tablets, reducing hospital visits and improving quality of life.
The drug targets eosinophils, a cause of inflammation in many attacks.
Researchers highlight its potential safety, fewer side effects compared to steroids, and home-use feasibility, though experts stress the need for increased lung health research funding.